News Release

March 18, 2004

Contact: Maureen McGuire, 860-679-4523
e-mail: mmcguire@nso.uchc.edu

Free Programs About In Vitro Fertilization: April 1, 15 & 29 at UConn Health Center

Farmington, Conn. - Specialists with the Center for Advanced Reproductive Services at the University of Connecticut Health Center, will lead informational sessions about current treatments for infertility and specifically, in vitro fertilization (IVF), on April 1, 15 and 29, at the Health Center. All sessions will run from 6 to 8:30 p.m.

The free programs are part of a series led by experts in the field of reproductive endocrinology: Claudio Benadiva, M.D., John Nulsen, M.D., and Donald Maier, M.D. For each program, the doctors will include an in-depth explanation of the IVF process and will discuss some of the emotional issues surrounding IVF.

For all sessions, pre-registration is required. For more information, directions and registration, please call 860-679-4324 or visit www.fertilitycenter-uconn.org.

The Center for Advanced Reproductive Services offers many advanced techniques to help patients achieve successful pregnancies. For more information about the Center, please call 860-679-4580 or visit the website at www.fertilitycenter-uconn.org. UConn, one of the first IVF centers in Connecticut, is now the largest center in the state.

UConn Health includes the schools of medicine and dental medicine, the UConn Medical Group, University Dentists, and John Dempsey Hospital. Home to Bioscience Connecticut, UConn Health pursues a mission of providing outstanding health care education in an environment of exemplary patient care, research and public service. More information about UConn Health is available at www.uchc.edu.

Note: News professionals are invited to visit the UConn Health Today news page (http://today.uchc.edu) for regularly updated news and feature stories, photos and media stories. News releases are archived at http://today.uchc.edu/newsreleases/2014. UConn Health news and information is also available on Facebook, Twitter and YouTube.